We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Injectable Polymer Helps Impede Severe Bleeding

By HospiMedica International staff writers
Posted on 25 Mar 2015
Print article
Image: Fibrin forming a blood clot, with PolySTAT (in blue) binding strands together (Photo courtesy of William Walker/University of Washington).
Image: Fibrin forming a blood clot, with PolySTAT (in blue) binding strands together (Photo courtesy of William Walker/University of Washington).
A new polymer helps develop a solid blood clot by fusing fibrin strands to each other, creating an interlinked web capable of withstanding pressure.

Developed by researchers at the University of Washington (Seattle, WA, USA), PolySTAT induces hemostasis by cross-linking the fibrin matrix within clots, mimicking the function of transglutaminase clotting factor XIII (fibrin stabilizing factor). The synthetic polymer circulates innocuously in the blood, identifies sites of vascular injury, and then promotes clot formation by binding specifically to fibrin monomers during polymerization, resulting in a fortified, hybrid polymer blood clot with enhanced resistance to enzymatic degradation.

The synthetic polymer also offers other advantages over conventional hemorrhaging treatments, as natural blood products are expensive, need careful storage, and can harbor bacteria or infectious diseases. PolySTAT can also strengthen clots even in cases where fibrin building blocks are critically low. It also uses a highly specific peptide that only binds to fibrin at the wound site, and does not bind to fibrin a precursors that circulate throughout the body, which could potentially lead to dangerous thrombi that can cause stroke or embolism.

In vivo hemostatic activity was confirmed in a rat model of trauma to the femoral artery and subsequent intravenous (IV) fluid resuscitation, in which intravenous administration of PolySTAT improved survival by reducing blood loss and fluid requirements. The researchers showed a 100% success rate in stopping bleeding to the otherwise lethal injury; for comparison, rats that were treated with albumin had only a 20% survival rate. The study describing the novel polymer was published in the March 4, 2015, issue of Science Translational Medicine.

“Most of the patients who die from bleeding die quickly,” said coauthor Assistant Professor of Emergency Medicine Nathan White, MD. “This is something you could potentially put in a syringe inside a backpack and give right away to reduce blood loss and keep people alive long enough to make it to medical care.”

Related Links:

University of Washington


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.